Literature DB >> 9774189

Ischemic preconditioning and superoxide dismutase protect against endothelial dysfunction and endothelium glycocalyx disruption in the postischemic guinea-pig hearts.

A Beresewicz1, E Czarnowska, M Maczewski.   

Abstract

UNLABELLED: The effect of ischemic preconditioning and superoxide dismutase (SOD) on endothelial glycocalyx and endothelium-dependent vasodilation in the postischemic isolated guinea-pig hearts was examined. Seven groups of hearts were used: group 1 underwent sham aerobic perfusion; group 2 was subjected to 40 min global ischemia without reperfusion; group 3, 40 min ischemia followed by 40 min reperfusion; group 4 was preconditioned with three cycles of 5 min global ischemia followed by 5 min of reperfusion (IPC), prior to 40 min ischemia; group 5 was subjected to IPC prior to standard ischemia/ reperfusion; group 6 underwent standard ischemia/reperfusion and SOD infusion (150 U/ml) was begun 5 min before 40 min ischemia and continued during the initial 5 min of the reperfusion period; group 7 was subjected to 80 min aerobic perfusion with NO-synthase inhibitor, L-NAME, to produce a model of endothelial dysfunction independent from the ischemia/reperfusion. Coronary flow responses to acetylcholine (ACh) and sodium nitroprusside (SNP) were used as measures of endothelium-dependent and endothelium-independent vascular function, respectively. Reduction in coronary flow caused by NO-synthase inhibitor, L-NAME, served as a measure of a basal endothelium-dependent vasodilator tone. After completion of each experimental protocol, the hearts were stained with ruthenium red or lanthanum chloride for electron microscopy evaluation of the endothelial glycocalyx. While ischemia led only to a slightly flocculent appearance of the glycocalyx, in ischemia/reperfused hearts the glycocalyx was disrupted, suggesting that it is the reperfusion injury which leads to the glycocalyx injury. Moreover, the coronary flow responses to ACh and L-NAME were impaired, while the responses to SNP were unchanged in the ischemia/reperfused hearts. The disruption of the glycocalyx and the deterioration of ACh and L-NAME responses was prevented by IPC. In addition, the alterations in the glycocalyx and the impairment of ACh responses were prevented by SOD. The glycocalyx appeared to be not changed in the hearts subjected to 80 min aerobic perfusion with L-NAME. IN
CONCLUSION: (1) the impairment of the endothelium-dependent coronary vasodilation is paralleled by the endothelial glycocalyx disruption in the postischemic guinea-pig hearts; (2) both these changes are prevented by SOD, suggesting the role of free radicals in the mechanism of their development; (3) both changes are prevented by IPC. We hypothesize, therefore, that alterations in the glycocalyx contribute to the mechanism of the endothelial dysfunction in the postischemic hearts.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9774189

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  41 in total

1.  Donors of nitric oxide mimic effects of ischaemic preconditioning on reperfusion induced arrhythmias in isolated rat heart.

Authors:  M Bilińska; M Maczewski; A Beresewicz
Journal:  Mol Cell Biochem       Date:  1996 Jul-Aug       Impact factor: 3.396

2.  Preconditioning does not attenuate myocardial stunning.

Authors:  M Ovize; K Przyklenk; S L Hale; R A Kloner
Journal:  Circulation       Date:  1992-06       Impact factor: 29.690

3.  Effect of ischaemic preconditioning on vascular dysfunction induced by ischaemia and reperfusion in rat hindquarters.

Authors:  K E Loke; O L Woodman
Journal:  Cardiovasc Res       Date:  1996-12       Impact factor: 10.787

4.  Ischemic preconditioning reduces Op6 generation and prevents respiratory impairment in the mitochondria of post-ischemic reperfused heart of rat.

Authors:  J W Park; Y S Chun; Y H Kim; C H Kim; M S Kim
Journal:  Life Sci       Date:  1997       Impact factor: 5.037

5.  Impaired canine coronary vasodilator response to acetylcholine and bradykinin after occlusion-reperfusion.

Authors:  J L Mehta; W W Nichols; W H Donnelly; D L Lawson; T G Saldeen
Journal:  Circ Res       Date:  1989-01       Impact factor: 17.367

6.  Hypoxia induced disruption of the cardiac endothelial glycocalyx: implications for capillary permeability.

Authors:  B J Ward; J L Donnelly
Journal:  Cardiovasc Res       Date:  1993-03       Impact factor: 10.787

7.  Long-term impairment of endothelium-dependent relaxations to aggregating platelets after reperfusion injury in canine coronary arteries.

Authors:  P J Pearson; H V Schaff; P M Vanhoutte
Journal:  Circulation       Date:  1990-06       Impact factor: 29.690

8.  Iron availability and free radical induced injury in the isolated ischaemic/reperfused rat heart.

Authors:  E Karwatowska-Prokopczuk; E Czarnowska; A Beresewicz
Journal:  Cardiovasc Res       Date:  1992-01       Impact factor: 10.787

9.  Preconditioning improves energy metabolism during reperfusion but does not attenuate myocardial stunning in porcine hearts.

Authors:  M Miyamae; H Fujiwara; M Kida; R Yokota; M Tanaka; M Katsuragawa; K Hasegawa; M Ohura; K Koga; Y Yabuuchi
Journal:  Circulation       Date:  1993-07       Impact factor: 29.690

10.  Diminished basal nitric oxide release after myocardial ischemia and reperfusion promotes neutrophil adherence to coronary endothelium.

Authors:  X L Ma; A S Weyrich; D J Lefer; A M Lefer
Journal:  Circ Res       Date:  1993-02       Impact factor: 17.367

View more
  14 in total

1.  NO news is good news.

Authors:  C J Lowenstein
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

Review 2.  The endothelial glycocalyx: composition, functions, and visualization.

Authors:  Sietze Reitsma; Dick W Slaaf; Hans Vink; Marc A M J van Zandvoort; Mirjam G A oude Egbrink
Journal:  Pflugers Arch       Date:  2007-01-26       Impact factor: 3.657

Review 3.  Reactive species-induced microvascular dysfunction in ischemia/reperfusion.

Authors:  Hong Yu; Ted Kalogeris; Ronald J Korthuis
Journal:  Free Radic Biol Med       Date:  2019-03-05       Impact factor: 7.376

Review 4.  The Endothelial Glycocalyx: A Possible Therapeutic Target in Cardiovascular Disorders.

Authors:  Anastasia Milusev; Robert Rieben; Nicoletta Sorvillo
Journal:  Front Cardiovasc Med       Date:  2022-05-13

5.  Effects of ischemic preconditioning on myocardium Caspase-3, SOCS-1, SOCS-3, TNF-α and IL-6 mRNA expression levels in myocardium IR rats.

Authors:  Jiangwei Ma; Zengyong Qiao; Biao Xu
Journal:  Mol Biol Rep       Date:  2013-10-05       Impact factor: 2.316

6.  Hypoxia/re-oxygenation-induced, redox-dependent activation of STAT1 (signal transducer and activator of transcription 1) confers resistance to apoptotic cell death via hsp70 induction.

Authors:  Keita Terui; Sanae Haga; Shin Enosawa; Naomi Ohnuma; Michitaka Ozaki
Journal:  Biochem J       Date:  2004-05-15       Impact factor: 3.857

7.  Cardiac ischemia and ischemia/reperfusion cause wide proteolysis of the coronary endothelial luminal membrane: possible dysfunctions.

Authors:  Blanca Arroyo-Flores; Erika Chi-Ahumada; Erika Briones-Cerecero; Alma Barajas-Espinosa; Sandra Perez-Aguilar; Ana Barba de la Rosa; Maureen Knabb; Rafael Rubio
Journal:  Open Cardiovasc Med J       Date:  2011-12-30

8.  Mechanisms of the beneficial actions of ischemic preconditioning on subcellular remodeling in ischemic-reperfused heart.

Authors:  By Alison L Müller; Naranjan S Dhalla
Journal:  Curr Cardiol Rev       Date:  2010-11

9.  Exogenous nitric oxide requires an endothelial glycocalyx to prevent postischemic coronary vascular leak in guinea pig hearts.

Authors:  Dirk Bruegger; Markus Rehm; Matthias Jacob; Daniel Chappell; Mechthild Stoeckelhuber; Ulrich Welsch; Peter Conzen; Bernhard F Becker
Journal:  Crit Care       Date:  2008-06-02       Impact factor: 9.097

10.  Ischaemic Preconditioning Protects Cardiomyocytes from Anthracycline-Induced Toxicity via the PI3K Pathway.

Authors:  Angshuman Maulik; Sean M Davidson; Izabela Piotrowska; Malcolm Walker; Derek M Yellon
Journal:  Cardiovasc Drugs Ther       Date:  2018-06       Impact factor: 3.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.